News & Updates

Daily use of somatropin, a recombinant human growth hormone (rhGH), led to significantly improved growth outcomes, particularly height standard deviation scores (HT-SDSs), in prepubertal children with idiopathic short stature (ISS), according to a recent study.

One year after undergoing percutaneous coronary intervention (PCI), high-risk patients on clopidogrel monotherapy have a reduced risk of multiple cardiovascular (CV) outcomes compared with those on aspirin monotherapy, according to a study presented at SCAI 2022.

Even a small degree of head rotation helps improve airway patency and reduce obstruction in patients with obstructive sleep apnoea (OSA), reports a recent study.

Coffee lovers now have more reasons to enjoy their drink, with a recent study showing that moderate consumption, whether sugar-sweetened or not, helps reduce the risk for death.

Blood test fibrosis-4 (FIB4) and vibration-controlled transient elastography (VCTE) can accurately classify patients with nonalcoholic fatty liver disease (NAFLD) who are at risk of liver-related events (LREs), suggests a recent study.

In the Disrupt PAD III trial, superior primary patency (PP) was achieved at 1 year with intravascular lithotripsy (IVL) plus a drug-coated balloon (DCB) compared with percutaneous transluminal angioplasty (PTA) + DCB, confirming the consistent safety and efficacy of IVL to facilitate a durable approach for individuals with heavily calcified femoropopliteal arteries largely without stent requirement.